Charles S Grob

Dr. Charles S. Grob is a Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences and Pediatrics at UCLA's David Geffen School of Medicine. His research focuses on novel psychopharmacological therapies, including pioneering studies on psilocybin, MDMA, and ayahuasca for psychiatric conditions. He investigates therapeutic applications for depression, anxiety, autism, and substance-related disorders, with emphasis on clinical trial methodology and ethical frameworks.

Research interests span:

• Psychedelic-assisted psychotherapy
• Ethics and policy in psychedelic medicine
• Neuropharmacology of hallucinogens
• Mental health interventions across diverse populations (adolescents, geriatric, oncology)

His publications demonstrate consistent focus on clinical translation of psychedelic therapies, with recent work emphasizing safety protocols, policy reform, and equitable access. Trends include increased attention to adolescent mental health, geriatric applications, and global health integration of traditional knowledge systems.

Dr. Grob collaborates extensively with institutions like UCSF and Johns Hopkins, contributing to consensus statements on psychedelic clinical care. He mentors emerging researchers in psychopharmacology and maintains active involvement in policy advocacy for responsible psychedelic medicine.